<DOC>
	<DOCNO>NCT00291109</DOCNO>
	<brief_summary>To assess quantitative real time PCR result oligonucleotide probes number gene transcription product may useful predictor indicator response letrozole</brief_summary>
	<brief_title>An Examination Predictors Indicators Response Letrozole 2.5 mg</brief_title>
	<detailed_description>To assess quantitative real time PCR result oligonucleotide probes number gene transcription product ( PCNA , cyclin-D1 , ER alpha , PR , pS2 , 450 aromatase , bcl-2 , bax , caspase-3 , VEGFR ) may useful predictor indicator response letrozole</detailed_description>
	<mesh_term>Letrozole</mesh_term>
	<criteria>evidence hyperplasia with/without atypia upon random periareolar fine needle aspiration breast hormone replacement therapy postmenopausal increase risk develop breast cancer base personal family history never take aromatase inhibitor selective estrogen receptor modulators last six month woman high risk breast cancer old 18 year anticoagulant mark breast tenderness pregnant within twelve month breast feeding/childbirth</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>breast atypia</keyword>
	<keyword>breast epithelial hyperplasia</keyword>
	<keyword>Ki-67</keyword>
	<keyword>RTPCR</keyword>
	<keyword>microdissection</keyword>
</DOC>